Abstract
Cancer corresponds to a set of diseases that have in common the disordered growth of cells, and have the capacity to invade neighboring and distant tissues and organs. Immunotherapy focused on the angiogenesis process may be an alternative to inhibit tumor growth. Based on this idea, our group successfully developed monoclonal antibodies (mAbs) that interfere with murine model tumor growt…